What is the prevalence of Juvenile Pilocytic Astrocytoma?

Juvenile pilocytic astrocytoma is considered a rare tumor, representing the most common primary brain tumor in children, with an annual incidence of approximately 0.5 to 0.8 cases per 100,000 children. While these tumors are typically diagnosed in the first two decades of life, they remain rare in the general population, and true prevalence is difficult to determine because many remain asymptomatic or are incidentally discovered.

What is the incidence and prevalence of juvenile pilocytic astrocytoma?

The incidence of juvenile pilocytic astrocytoma is estimated at roughly 0.5 to 0.8 per 100,000 individuals per year, according to data from the Central Brain Tumor Registry of the United States (CBTRUS). Because these tumors often grow slowly and can be managed effectively, the prevalence—the total number of people living with juvenile pilocytic astrocytoma—is higher than the incidence, though precise global counts are limited by the lack of centralized rare disease registries.

Who is most commonly affected by juvenile pilocytic astrocytoma?

Juvenile pilocytic astrocytoma displays specific demographic patterns that help clinicians in diagnosis:

• Age of Onset: The peak age of diagnosis is between 5 and 14 years old; it is rarely diagnosed in adults.


• Gender Distribution: There is no significant difference in incidence between males and females; both are affected at similar rates.


• Geographic/Ethnic Variation: Current clinical literature does not suggest significant geographic or ethnic predispositions for juvenile pilocytic astrocytoma.

Why is collecting data on juvenile pilocytic astrocytoma challenging?

Accurate prevalence data for juvenile pilocytic astrocytoma is often hampered by underdiagnosis. Some tumors are small, slow-growing, and may be discovered incidentally during imaging for unrelated issues. At DiseaseMaps.org, we have seen 13 people with juvenile pilocytic astrocytoma join our community to share their lived experiences, which provides a vital, real-world perspective that complements traditional clinical statistics.

Next steps

• Consult a pediatric neuro-oncologist to discuss specific tumor location and management options.


• Join the juvenile pilocytic astrocytoma community at DiseaseMaps.org to connect with others sharing similar diagnostic journeys.


• Request genetic counseling if your medical team suspects a link to neurofibromatosis type 1 (NF1), which is associated with a subset of these cases.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Central Brain Tumor Registry of the United States (CBTRUS) Statistical Reports.


• NIH Genetic and Rare Diseases Information Center (GARD).


• Orphanet: The portal for rare diseases and orphan drugs.


• World Health Organization (WHO) Classification of Tumours of the Central Nervous System.